• About us
• Contact

Advertisement

Product › Details

TheraT® technology

	Next higher product group	arenavirus vector platform
	Status	2016-10-17 development existent
	Organisation	Hookipa Biotech AG
	Group	Hookipa (Group)

Record changed: 2019-07-14

Advertisement

More documents for TheraT® technology

• [1] Hookipa Pharma Inc.. (5/8/19). "Press Release: Hookipa Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
• [2] Hookipa Pharma Inc.. (2/26/19). "Press Release: Hookipa Pharma Raises $37.4 Million (€33.2 Million) in Series D Financing". New York, NY & Vienna....
• [3] Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
• [4] Hookipa Pharma Inc.. (11/14/18). "Press Release: Hookipa Appoints Julie O’Neill as a Non-Executive Director". New York, NY & Vienna....
• [5] Hookipa Biotech AG. (6/5/18). "Press Release: Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B". Vienna & Foster City, CA....
• [6] Hookipa Biotech AG. (10/18/17). "Press Release: Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors". Vienna....
• [7] Hookipa Biotech AG. (4/19/17). "Press Release: Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech". Vienna....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.